Abitec
ABITEC is a global leader in pharmaceutical-grade lipids, meeting USP/NF and EP standards. ABITEC lipids enhance bioavailability, solubilization, permeation, and more. ABITEC offers a range of products like CAPTEX™, CAPMUL™, ACCONON™, and STEROTEX™, contributing to diverse pharmaceutical applications.
CAPMUL GDB EP/NF
CAPMUL GDB EP/NF increase solubility and bioavailability of API. Glyceryl Dibehenate USP/NF and Glycerol Dibehena...Show More
CAPMUL GDB EP/NF increase solubility and bioavailability of API. Glyceryl Dibehenate USP/NF and Glycerol Dibehenate EP.
Show Less
Pharmaceutical Ingredients
| Physical form: | Powder |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets |
CAPMUL MCM EP/NF
CAPMUL® MCM EP/NF Mixture of monoacylglycerols, obtained by direct esterification of glycerol with caprylic ...Show More
CAPMUL® MCM EP/NF Mixture of monoacylglycerols, obtained by direct esterification of glycerol with caprylic (octanoic) and capric (decanoic) acids.
Show Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Solutions |
CAPMUL PG-8 NF
CAPMUL PG-8 NF increase solubility and bioavailability of API. Propylene Glycol Monocaprylate Type II USP/NF
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Solutions |
CAPMUL INJ MCM EP/NF
CAPMUL INJ MCM EP/NF increase solubility and bioavailability of API. Glycerol Monocaprylate, Type I EP, Glyceryl Mo...Show More
CAPMUL INJ MCM EP/NF increase solubility and bioavailability of API. Glycerol Monocaprylate, Type I EP, Glyceryl Monocaprylocaprate, Type I USP/ NF; (Mono-and Di- Glycerides USP/NF, if tested)Show Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Solutions |
CAPMUL 808G EP/NF
CAPMUL 808G EP/NF increase solubility and bioavailability of API. Glycerol Monoaprylate Type "EP, Glycerol Monocapr...Show More
CAPMUL 808G EP/NF increase solubility and bioavailability of API. Glycerol Monoaprylate Type "EP, Glycerol Monocaprylate Type II USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Solid |
| Application: | Lipid, Solutions |
CAPMUL GMO 50 EP/NF
CAPMUL GMO 50 EP/NF increase solubility and bioavailability of API. Glyceryl Monooleate EP; Glyceryl Monooleate US...Show More
CAPMUL GMO 50 EP/NF increase solubility and bioavailability of API. Glyceryl Monooleate EP; Glyceryl Monooleate USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Semi-solid |
| Application: | Lipid, Solutions, Topical |
CAPMUL PG-2L EP
CAPMUL PG-2L EP increase solubility and bioavailability of API. Propylene Glycol Dilaurate EP; Propylene Glycol Di...Show More
CAPMUL PG-2L EP increase solubility and bioavailability of API. Propylene Glycol Dilaurate EP; Propylene Glycol Dilaurate USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Syrups, Solutions, Suspensions, Solutions |
CAPMUL PG-8-70 NF
CAPMUL PG-8-70 NF increase solubility and bioavailability of API. Propylene Glycol Monocaprylate Type II USP/NF
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Pellets, Solutions |
CAPMUL PG-12 EP/NF
CAPMUL PG-12 EP/NF increase solubility and bioavailability of API. Propylene Glycol Monolaurate Type II EP; Propyl...Show More
CAPMUL PG-12 EP/NF increase solubility and bioavailability of API. Propylene Glycol Monolaurate Type II EP; Propylene Glycol Monolaurate Type II USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Solutions |
CAPTEX 8000
CAPTEX 8000 increase solubility and bioavailability of API. Medium-Chain (fatty acid) Triglyceride JPE; Glycerol E...Show More
CAPTEX 8000 increase solubility and bioavailability of API. Medium-Chain (fatty acid) Triglyceride JPE; Glycerol Esters of fatty acid JSFA, TricaprylinShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Capsules, Granules, Lipid, Pellets, Solutions, Supplement, Suspensions, Syrups, Tablets, Topical |
CAPTEX 200 P
CAPTEX 200 P increase solubility and bioavailability of API. Propylene Glycol Dicaprylocaprate EP, Propylene Glyco...Show More
CAPTEX 200 P increase solubility and bioavailability of API. Propylene Glycol Dicaprylocaprate EP, Propylene Glycol Dicaprylate/Dicaprate USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Tablets, Capsules, Granules, Lipid, Pellets, Syrups, Solutions, Suspensions |
CAPTEX 170 EP
CAPTEX 170 EP increase solubility and bioavailability of API. Cocoyl Caprylocaprate EP
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Topical, Solutions |
CAPTEX INJ 8000
CAPTEX INJ 8000 increase solubility and bioavailability of API. Medium -Chain (fatty acid) Triglyceride JPE, Glycer...Show More
CAPTEX INJ 8000 increase solubility and bioavailability of API. Medium -Chain (fatty acid) Triglyceride JPE, Glycerol Esters of Fatty acids JSFA, TricaprylinShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Injectables and Parenterals, Lipid |
CAPTEX 300 EP/NF
CAPTEX 300 EP/NF increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-Chain Trigl...Show More
CAPTEX 300 EP/NF increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-Chain Triglycerides USP/NF.Show Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Capsules, Granules, Lipid, Pellets, Solutions, Supplement, Suspensions, Syrups, Tablets, Topical |
Captex 355 EP/NF/JPE
Captex 355 EP/NF/JPE increase solubility and bioavailability of API. Medium-CHAIN: Triglycerides EP; Medium-Chain T...Show More
Captex 355 EP/NF/JPE increase solubility and bioavailability of API. Medium-CHAIN: Triglycerides EP; Medium-Chain Triglycerides USP/NF; Medium-Chain Fatty Acid Triglyceride JPEShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Capsules, Lipid, Pellets, Solutions, Supplement, Suspensions, Syrups, Tablets, Topical |
CAPTEX 355 INJ EP/NF
CAPTEX 355 INJ EP/NF increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-Chain T...Show More
CAPTEX 355 INJ EP/NF increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-Chain Triglycerides USP/NF; Medium-Chain Fatty Acid Triglyceride JPEShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Injectables and Parenterals, Lipid |
CAPTEX 300 LOW C6 EP/NF/JPE
CAPTEX 300 LOW C6 EP/NF/JPE increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-C...Show More
CAPTEX 300 LOW C6 EP/NF/JPE increase solubility and bioavailability of API. Medium-Chain Triglycerides EP; Medium-Chain Triglycerides USP/NF; Medium-Chain Fatty acid Triglycerides JPEShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Capsules, Granules, Lipid, Pellets, Solutions, Supplement, Suspensions, Syrups, Tablets, Topical |
ACCONON C-50 EP/NF
ACCONON C-50 EP/NF increase solubility and bioavailability of API. Stearoyl Macrogol glycerides EP; Stearoyl Polyoxy...Show More
ACCONON C-50 EP/NF increase solubility and bioavailability of API. Stearoyl Macrogol glycerides EP; Stearoyl Polyoxyglicerides USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Solid |
| Application: | Lipid, Solutions |
ACCONON AKG-6 EP/NF
ACCONON AKG-6 EP/NF increase solubility and bioavailability of API. Oleayl Macrogol glycerides EP; Oleoyl Polyoxygly...Show More
ACCONON AKG-6 EP/NF increase solubility and bioavailability of API. Oleayl Macrogol glycerides EP; Oleoyl Polyoxyglycerides USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Lipid, Solutions |
ACCONON C-44 EP/ NF
ACCONON C-44 EP/ NF increase solubility and bioavailability of API. Lauroyl Macrogol glycerides EP; Lauroyl Polyoxyl...Show More
ACCONON C-44 EP/ NF increase solubility and bioavailability of API. Lauroyl Macrogol glycerides EP; Lauroyl Polyoxylglycerides USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Solid |
| Application: | Lipid, Solutions |
ACCONON MC8-2 EP/NF
ACCONON MC8-2 EP/NF increase solubility and bioavailability of API. Caprylocaproyl Macrogol glycerides EP; Capryloc...Show More
ACCONON MC8-2 EP/NF increase solubility and bioavailability of API. Caprylocaproyl Macrogol glycerides EP; Caprylocaproyl Polyoxylglycerides USP/NFShow Less
Pharmaceutical Ingredients
| Physical form: | Liquid |
| Application: | Lipid, Solutions |
STEROTEX NF
STEROTEX NF increase solubility and bioavailability of API. Hydrogenated vegetable Oil type I USP/NF
Pharmaceutical Ingredients
| Physical form: | Powder |
| Application: | Capsules, Granules, Lipid, Pellets, Tablets |
STEROTEX K, NF
STEROTEX K, NF increase solubility and bioavailability of API. Hydrogenated Vegetable Oil type I USP/NF
Pharmaceutical Ingredients
| Physical form: | Powder |
| Application: | Capsules, Granules, Lipid, Pellets, Tablets |
| Requestor's contact details | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.